key: cord-1002502-5ksftump
authors: Morena, Francesco; Argentati, Chiara; Tortorella, Ilaria; Emiliani, Carla; Martino, Sabata
title: De novo ssRNA Aptamers against the SARS-CoV-2 Main Protease: In Silico Design and Molecular Dynamics Simulation
date: 2021-06-26
journal: Int J Mol Sci
DOI: 10.3390/ijms22136874
sha: cebd80c22b26a7aeb7588fed61ad6ed453e6e6a4
doc_id: 1002502
cord_uid: 5ksftump

Herein, we have generated ssRNA aptamers to inhibit SARS-CoV-2 M(pro), a protease necessary for the SARS-CoV-2 coronavirus replication. Because there is no aptamer 3D structure currently available in the databanks for this protein, first, we modeled an ssRNA aptamer using an entropic fragment-based strategy. We refined the initial sequence and 3D structure by using two sequential approaches, consisting of an elitist genetic algorithm and an RNA inverse process. We identified three specific aptamers against SARS-CoV-2 M(pro), called MApta(pro), MApta(pro)-IR1, and MApta(pro)-IR2, with similar 3D conformations and that fall in the dimerization region of the SARS-CoV-2 M(pro) necessary for the enzymatic activity. Through the molecular dynamic simulation and binding free energy calculation, the interaction between the MApta(pro)-IR1 aptamer and the SARS-CoV-2 M(pro) enzyme resulted in the strongest and the highest stable complex; therefore, the ssRNA MApta(pro)-IR1 aptamer was selected as the best potential candidate for the inhibition of SARS-CoV-2 M(pro) and a perspective therapeutic drug for the COVID-19 disease.

Currently, there is no available therapy for the Coronavirus Disease 2019 (COVID-19), a pandemic caused by a novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that began in December 2019 and accounted for more than 3.4 million deaths of infected patients in the world (as of May 2021) [1] . In a short time, considerable efforts have been made worldwide to develop strategies to combat the disease progression through a combination of drugs already used for other virus pandemics, or with new molecules being discovered [2] [3] [4] . In the meantime, efforts have been made to produce several vaccines to prevent disease infection [5] [6] [7] [8] . However, this hope has been tempered mostly by the absence of an effective antiviral drug as well as by logistical and vaccine manufacturing troubles. Additionally, the current discovery of new variants of SARS-CoV-2 [9, 10] raises more questions about the virus epidemiology in the scientific community.

The SARS-CoV-2 is a single-stranded RNA virus that shares~80% and~50% sequence identity with the other coronaviridae SARS-CoV and MERS-CoV [11] , respectively. The SARS-CoV-2 genome consists of 14 open reading frames (ORF) that encode for the 4 structural proteins (spike [S] , envelope [E] , membrane [M] , and nucleocapsid [N]), 9 accessory proteins, and the 16 non-structural proteins (NSPs) [12] . The spike protein binds specifically to the angiotensin-converting enzyme 2 (ACE2) receptor of the cells, and, by this, mediates the entry of the SARS-CoV-2 virus into the cells. It was suggested that ACE2 binds the S1 subunit of the spike protein at the receptor-binding domain and that this interaction in silico, and have optimized the primary sequences and the conformation stability to refining the binding properties, and to select the aptamer against SARS-CoV-2 M pro with the highest inhibition potential.

Currently, there are no available aptamers against M pro protein in databanks or the literature; therefore, we have designed and generated a de novo single strand (ss)RNA aptamer against the M pro protein; then, we have used this aptamer as a model to generate aptamers with the highest specificity toward the M pro protein. Figure 1 schematizes the workflow for the production of the against-M pro ssRNA aptamer.

In this study, we used the computational approach to develop single-stranded (ss)RNA aptamers against the SARS-CoV-2 M pro protein which could thereby block the SARS-CoV-2 viral replication. We have designed de novo ssRNA aptamers against SARS-CoV-2 M pro in silico, and have optimized the primary sequences and the conformation stability to refining the binding properties, and to select the aptamer against SARS-CoV-2 M pro with the highest inhibition potential.

Currently, there are no available aptamers against M pro protein in databanks or the literature; therefore, we have designed and generated a de novo single strand (ss)RNA aptamer against the M pro protein; then, we have used this aptamer as a model to generate aptamers with the highest specificity toward the M pro protein. Figure 1 schematizes the workflow for the production of the against-M pro ssRNA aptamer. First, we generated de novo an initial 30mer 3D ssRNA aptamer structure against M pro by Making Aptamers Without SELEX algorithm (MAWS) [36] ( Figure 1A ). The obtained structure was extended to 40mer by adding 5′-GGGGG and 3′-CCCCC sequences ( Figure  1A ) and subjected to the first optimization step ( Figure 1B) , consisting of sequence mutation and optimization by using the Mutate Predict Dock Repeat (MPDR) algorithm [37] , First, we generated de novo an initial 30mer 3D ssRNA aptamer structure against M pro by Making Aptamers Without SELEX algorithm (MAWS) [36] ( Figure 1A ). The obtained structure was extended to 40mer by adding 5 -GGGGG and 3 -CCCCC sequences ( Figure 1A ) and subjected to the first optimization step ( Figure 1B) , consisting of sequence mutation and optimization by using the Mutate Predict Dock Repeat (MPDR) algorithm [37] , virtual screening and re-docking analyses, and selection of the best ssRNA aptamer structure ( Figure 1B) . The latter was subjected to the second optimization step ( Figure 1C) , consisting of the RNA inverse process optimization, virtual screening and re-docking analysis, and selection of the best ssRNA aptamers based on the concordance of scores between software. The best aptamer structures selected from the first and second optimization steps were subjected to molecular dynamics (MD) simulations in complex with M pro ( Figure 1D ). The MD simulation trajectories were used as inputs for the calculation of binding free energies of the aptamers and the investigation of their binding mechanism for the final selection of the best ssRNA aptamer against M pro ( Figure 1D ).

Many bioinformatics approaches have been carried out to discover novel aptamers [38, 39] , as well as to probe and assess the aptamer-protein interactions [40] [41] [42] . We used the iGEM MAWS algorithm [36] with some personal modifications (see method Section 4.1) to produce a 30mer ssRNA aptamer (Figure 2A ) specific for the M pro crystallography structure (PDB #6LU7) [18] . This RNA sequence was used to evolve the 30mer aptamer to a final length of 40mer by adding 5'-GGGGG and 3'-CCCCC sequences to the aptamer terminal ends (Figure 2A ). The length of 40mer allowed the generation of an aptamer with a suitable size for covering the designed target region of M pro .

virtual screening and re-docking analyses, and selection of the best ssRNA aptamer structure ( Figure 1B) . The latter was subjected to the second optimization step ( Figure 1C) , consisting of the RNA inverse process optimization, virtual screening and re-docking analysis, and selection of the best ssRNA aptamers based on the concordance of scores between software.

The best aptamer structures selected from the first and second optimization steps were subjected to molecular dynamics (MD) simulations in complex with M pro ( Figure  1D ). The MD simulation trajectories were used as inputs for the calculation of binding free energies of the aptamers and the investigation of their binding mechanism for the final selection of the best ssRNA aptamer against M pro ( Figure 1D ).

Many bioinformatics approaches have been carried out to discover novel aptamers [38, 39] , as well as to probe and assess the aptamer-protein interactions [40] [41] [42] . We used the iGEM MAWS algorithm [36] with some personal modifications (see method Section 4.1) to produce a 30mer ssRNA aptamer (Figure 2A ) specific for the M pro crystallography structure (PDB #6LU7) [18] . This RNA sequence was used to evolve the 30mer aptamer to a final length of 40mer by adding 5'-GGGGG and 3'-CCCCC sequences to the aptamer terminal ends (Figure 2A ). The length of 40mer allowed the generation of an aptamer with a suitable size for covering the designed target region of M pro . Next, we performed the first optimization step by using the MPDR algorithm. From the 40mer RNA aptamer (Figure 2A) , 200 mutated and optimized sequences were generated, which were then used to create a logo representation ( Figure 2B ). The logo representation showed that the majority of generated sequences were stable and not skewed in favor of some of the other ssRNA ( Figure 2B ). All 200 sequences (ssRNAs) were converted to the co-respective 3D structures through SimRNA 3D and optimized with QRNAS algorithms through MPDR, and the latter were used as ligands to predict their binding specificity toward the M pro enzyme by molecular docking analysis.

The identification of the best de novo 3D ssRNAs aptamer was performed by three different docking platforms: ZDOCK, HDOCK, and QVINA-W. Only aptamers showing favorable and equivalent binding modes in all three tools were considered as actives. ZDOCK was used as the first step to dimensionally reduce the 200 ssRNA aptamer structures to the best 10 because it is faster in the screening process due to its algorithm, and it gives the possibility of parallel execution. Thus, we performed a docking analysis using a set of 13 random X-ray-resolved ssRNA aptamer structures, stripped from the protein Next, we performed the first optimization step by using the MPDR algorithm. From the 40mer RNA aptamer (Figure 2A) , 200 mutated and optimized sequences were generated, which were then used to create a logo representation ( Figure 2B ). The logo representation showed that the majority of generated sequences were stable and not skewed in favor of some of the other ssRNA ( Figure 2B ). All 200 sequences (ssRNAs) were converted to the co-respective 3D structures through SimRNA 3D and optimized with QRNAS algorithms through MPDR, and the latter were used as ligands to predict their binding specificity toward the M pro enzyme by molecular docking analysis.

The identification of the best de novo 3D ssRNAs aptamer was performed by three different docking platforms: ZDOCK, HDOCK, and QVINA-W. Only aptamers showing favorable and equivalent binding modes in all three tools were considered as actives. ZDOCK was used as the first step to dimensionally reduce the 200 ssRNA aptamer structures to the best 10 because it is faster in the screening process due to its algorithm, and it gives the possibility of parallel execution. Thus, we performed a docking analysis using a set of 13 random X-ray-resolved ssRNA aptamer structures, stripped from the protein complexes in the PDB database (PDB.org, February 2021; Table S1), and set up the threshold value of ZDOCK score, docking these structures against M pro .

From the first best pose of each docked 13 X-ray structure (Table S1 ), we calculated the ZDOCK mean, which corresponded to 1370 ± 83, and by this, we have set the threshold ZDOCK score to 1536 (1370 + 2SD). Two hundred docking experiments using ZDOCK algorithms were carried out to predict the most probable aptamer in the collected sets of structures, and the top 10 aptamer-M pro complexes were selected for a further re-docking process step with HDOCK and QVINA-W (Table 1) . The ZDOCK top 10 aptamers were re-docked integrating HDOCK and QVINA-W algorithms and, based on (i) the concordance of the three docking algorithms scores, and (ii) the same pose predicted by all algorithms (Table 1) , the sequence 5 -GGCGGCGGAGCGGGG UGGGCGGUUUGAAUCCCAUAGGUGC-3 was identified as the best one that gives rise to the most specific 3D ssRNA structure against M pro . We call this aptamer MApta pro ( Figure 3A ). the ZDOCK mean, which corresponded to 1370  83, and by this, we have set the threshold ZDOCK score to 1536 (1370 + 2SD). Two hundred docking experiments using ZDOCK algorithms were carried out to predict the most probable aptamer in the collected sets of structures, and the top 10 aptamer-M pro complexes were selected for a further re-docking process step with HDOCK and QVINA-W (Table 1) . The ZDOCK top 10 aptamers were re-docked integrating HDOCK and QVINA-W algorithms and, based on (i) the concordance of the three docking algorithms scores, and (ii) the same pose predicted by all algorithms (Table 1) , the sequence 5′-GGCGGCG-GAGCGGGGUGGGCGGUUUGAAUCCCAUAGGUGC-3′ was identified as the best one that gives rise to the most specific 3D ssRNA structure against M pro . We call this aptamer MApta pro ( Figure 3A ).

The identified pose had the lowest docking energy with a score of 1738.34, -340, and -17.4 (ZDOCK, HDOCK, and QVINA-W, respectively) (Table 1) , almost due to the four hydrogen bonds with ASN-133, ARG-222, TYR-237, and ARG-279 ( Figure 3B ) (distance below 3Å between donor and acceptor atoms; for detailed interaction see Figure S1 Figure S1 in Supplementary file).

The identified pose had the lowest docking energy with a score of 1738.34, −340, and −17.4 (ZDOCK, HDOCK, and QVINA-W, respectively) (Table 1) , almost due to the four hydrogen bonds with ASN-133, ARG-222, TYR-237, and ARG-279 ( Figure 3B ) (distance below 3Å between donor and acceptor atoms; for detailed interaction see Figure S1 in the Supplementary File), and two hydrophobic interactions with ASN-221 and ARG-222 ( Figure S1 ).

Next, we used the above-described aptamer MApta pro to generate aptamers with the highest binding specificity toward the M pro protein. We have chosen the elitism-based algorithm in MPDR in the interest of time, even if it can be trapped in local optima.

To mitigate this event, the secondary structure was derived from the best pose of the MApta pro aptamer (Figures 3 and 4A ,B) and subjected to an inverse RNA folding process ( Figure 1C ) to predict the sequences that fold into a target minimum free energy secondary structure, taking into account several constraints. 

Next, we used the above-described aptamer MApta pro to generate aptamers with the highest binding specificity toward the M pro protein. We have chosen the elitism-based al gorithm in MPDR in the interest of time, even if it can be trapped in local optima.

To mitigate this event, the secondary structure was derived from the best pose of the MApta pro aptamer (Figures 3 and 4A ,B) and subjected to an inverse RNA folding process ( Figure 1C ) to predict the sequences that fold into a target minimum free energy second ary structure, taking into account several constraints. 

Inverse RNA folding is traditionally designed to optimize RNAs with favorable properties. Using an RNAinverse web server [43, 44] , we obtained 207 sequences (supple mentary file "Output of RNAinverse WebServer") that were post-processed with the pipe line used for the generation of the above described ssRNA MApta pro aptamer ( Figure 1 ) In this process, we used the ViennaRNA algorithm for secondary structure prediction in favor of the energy minimization, the SimRNA algorithm for the prediction of the 3D structure from the primary sequence and the secondary structure, and the QRNA algo rithm for finally refining and minimize the 3D structure of aptamer for subsequent dock ing.

We performed molecular docking according to the previous workflow ( Figure 1C ) Hence, after dimensional reduction with ZDOCK docking of the sequences generated from the first aptamer MApta pro , the best structures were re-docked with HDOCK, and QVINA-W, and chosen based on (i) the concordance of the three docking algorithms scores, and (ii) the same pose predicted by all algorithms.

We identified only two structures with a score over the ZDOCK threshold value o 1536 as probable aptamers for the M pro protein. Both structures have shown a bette ZDOCK score compared to MApta pro aptamer but a lower score in HDOCK and QVINA W ( Table 2 ). 

Inverse RNA folding is traditionally designed to optimize RNAs with favorable properties. Using an RNAinverse web server [43, 44] , we obtained 207 sequences (Supplementary file "Output of RNAinverse WebServer") that were post-processed with the pipeline used for the generation of the above described ssRNA MApta pro aptamer ( Figure 1 ). In this process, we used the ViennaRNA algorithm for secondary structure prediction in favor of the energy minimization, the SimRNA algorithm for the prediction of the 3D structure from the primary sequence and the secondary structure, and the QRNA algorithm for finally refining and minimize the 3D structure of aptamer for subsequent docking.

We performed molecular docking according to the previous workflow ( Figure 1C ). Hence, after dimensional reduction with ZDOCK docking of the sequences generated from the first aptamer MApta pro , the best structures were re-docked with HDOCK, and QVINA-W, and chosen based on (i) the concordance of the three docking algorithms scores, and (ii) the same pose predicted by all algorithms.

We identified only two structures with a score over the ZDOCK threshold value of 1536 as probable aptamers for the M pro protein. Both structures have shown a better ZDOCK score compared to MApta pro aptamer but a lower score in HDOCK and QVINA-W ( Table 2 ). The aptamers were called MApta pro -IR1 (GGCGGCGAAACGGAGCUCCCAGGG AAUGGUCCAAAGGCGC) and MApta pro -IR2 (GGCGGUGGAAAGGGGAAUGCGGCAU-GAUGCCCGUAGGUGC), and related structures are reported in Figure 5A ,B. The aptamers were called MApta pro -IR1 (GGCGGCGAAAC-GGAGCUCCCAGGGAAUGGUCCAAAGGCGC) and MApta pro -IR2 (GGCGGUG-GAAAGGGGAAUGCGGCAUGAUGCCCGUAGGUGC), and related structures are reported in Figure 5A ,B. The ssRNA aptamers MApta pro -IR1 and MApta pro -IR2 have the lowest docking energy of −15.69 kcal/mol and −13.61 kcal/mol, respectively ( Table 2 ) and formed three hydrogen bonds that resulted importantly in tethering with the M pro . Specifically, the MApta pro -IR1 aptamer arranged hydrogen bonds with SER-123, SER-139, and ASN-277 residues of M pro ( Figures 5C and S2) , and the MApta pro -IR2 aptamer engaged hydrogen bonds with LYS-137, ASN-238, and TYR-239 residues of M pro ( Figures 5D and S3 ). No hydrophobic interactions were found ( Figures S2 and S3) .

Thus, from the original MApta pro , the InverseRNA approach generated two ssRNA aptamers with similar 3D conformations, comparable docking scores and that were favorable to forming the complex with the protein. Notably, MApta pro -IR1 and MApta pro -IR2, as well as MApta pro , fall in the same region of M pro ( Figure 6 ). The ssRNA aptamers MApta pro -IR1 and MApta pro -IR2 have the lowest docking energy of −15.69 kcal/mol and −13.61 kcal/mol, respectively ( Table 2 ) and formed three hydrogen bonds that resulted importantly in tethering with the M pro . Specifically, the MApta pro -IR1 aptamer arranged hydrogen bonds with SER-123, SER-139, and ASN-277 residues of M pro ( Figure 5C and Figure S2 ), and the MApta pro -IR2 aptamer engaged hydrogen bonds with LYS-137, ASN-238, and TYR-239 residues of M pro ( Figure 5D and Figure S3 ). No hydrophobic interactions were found ( Figures S2 and S3) .

Thus, from the original MApta pro , the InverseRNA approach generated two ssRNA aptamers with similar 3D conformations, comparable docking scores and that were favorable to forming the complex with the protein. Notably, MApta pro -IR1 and MApta pro -IR2, as well as MApta pro , fall in the same region of M pro ( Figure 6 ). 

We used the AMBER software to ensure the efficacy interaction of MApta pro , MApta pro -IR1, and MApta pro -IR2 aptamers with the M pro protein. The simulation time of the dynamic stability process was over 100 ns. We applied canonical analytical methods to analyze the structural stability of biomacromolecules in molecular dynamics (MD) simulation: (i) root-mean-square deviation from the initial simulation structure; (ii) the radius of gyration identifying the structure stability and compactness of modeled conformation (iii) the number of hydrogen bonds, and (iv) the binding free energy analysis.

The RMSD plot of the three aptamers, and principal component analysis (PCA), revealed some differences among the aptamer structures during the 100 ns simulation time ( Figures 7A and S4) . MApta pro had the highest RMSD of 4.37Å with an average of 3.37 ± 0.64Å and showed some fluctuations. The aptamer-protein interaction attempts to reach an equilibrium state with an oscillation of 3Å after 12 ns. This new state was lost after 5 ns of simulation, as the RMSD increased steadily until 30 ns when reaching a new equilibrium state ( Figure 7A ). The equilibrium state was observed after 20 ns with a fluctuation of 4Å and 3Å for both MApta pro -IR1 and MApta pro -IR2 complexes, respectively. The highest RMSD values for MApta pro -RI1 was 5.40Å with an average of 4.25 ± 0.66Å , while the MApta pro -RI2 RMSD was 4.04Å with an average of 3.14 ± 0.43Å . In both cases the equilibrium state continued over the simulation time ( Figure 7B ,C). 

We used the AMBER software to ensure the efficacy interaction of MApta pro , MApta pro -IR1, and MApta pro -IR2 aptamers with the M pro protein. The simulation time of the dynamic stability process was over 100 ns. We applied canonical analytical methods to analyze the structural stability of biomacromolecules in molecular dynamics (MD) simulation: (i) root-mean-square deviation from the initial simulation structure; (ii) the radius of gyration identifying the structure stability and compactness of modeled conformation (iii) the number of hydrogen bonds, and (iv) the binding free energy analysis.

The RMSD plot of the three aptamers, and principal component analysis (PCA), revealed some differences among the aptamer structures during the 100 ns simulation time ( Figure 7A and Figure S4 ). MApta pro had the highest RMSD of 4.37Å with an average of 3.37 ± 0.64Å and showed some fluctuations. The aptamer-protein interaction attempts to reach an equilibrium state with an oscillation of 3Å after 12 ns. This new state was lost after 5 ns of simulation, as the RMSD increased steadily until 30 ns when reaching a new equilibrium state ( Figure 7A ). The equilibrium state was observed after 20 ns with a fluctuation of 4Å and 3Å for both MApta pro -IR1 and MApta pro -IR2 complexes, respectively. The highest RMSD values for MApta pro -RI1 was 5.40Å with an average of 4.25 ± 0.66Å, while the MApta pro -RI2 RMSD was 4.04Å with an average of 3.14 ± 0.43Å. In both cases the equilibrium state continued over the simulation time ( Figure 7B ,C). The Rg trajectory plot of the MApta pro -IR1/M pro complex was stable after 20 ns, and the oscillation values were negligible ( Figure 8B ). After that, the complex was at equilibrium and confirmed the steady interaction between the aptamer and the protein. This value remained virtually unchanged during the simulation time with an Rg average of 25.94 ± 0.35Å for the MApta pro -RI1/M pro complex ( Figure 8B) .

Finally, the MApta pro -IR2/M pro complex had an Rg average of 23.04 ± 0.13Å and was stable after 20 ns with a slight oscillation around 35 ns ( Figure 8C ). 

The number of intramolecular H-bonds formed is a measure of the aptamer-protein interaction stability. The total number of H-bonds from MApta pro , MApta pro -IR1, and MApta pro -IR2 in complex with the main protease M pro is shown in Figure 9 . During the simulation time, the number of H-bonds in the MApta pro /M pro complex decreased, while the number of stable H-bonds in the MApta pro -IR1/M pro and MApta pro -IR2/M pro complexes remained nearly unchanged. The average number of H-bonds was 11.46 ± 2.59 for MApta pro , with the lowest number being four H-bonds, while the average number of Hbonds was 9.67 ± 2.13 for MApta pro -IR1, with the lowest number being three H-bonds, and was 7.96 ± 1.98 with the lowest number being three H-bonds for MApta pro -IR2 (Figure 9 , Table 3 ). The Rg trajectory plot of the MApta pro -IR1/M pro complex was stable after 20 ns, and the oscillation values were negligible ( Figure 8B ). After that, the complex was at equilibrium and confirmed the steady interaction between the aptamer and the protein. This value remained virtually unchanged during the simulation time with an Rg average of 25.94 ± 0.35Å for the MApta pro -RI1/M pro complex ( Figure 8B) .

Finally, the MApta pro -IR2/M pro complex had an Rg average of 23.04 ± 0.13Å and was stable after 20 ns with a slight oscillation around 35 ns ( Figure 8C ). 

The number of intramolecular H-bonds formed is a measure of the aptamer-protein interaction stability. The total number of H-bonds from MApta pro , MApta pro -IR1, and MApta pro -IR2 in complex with the main protease M pro is shown in Figure 9 . During the simulation time, the number of H-bonds in the MApta pro /M pro complex decreased, while the number of stable H-bonds in the MApta pro -IR1/M pro and MApta pro -IR2/M pro complexes remained nearly unchanged. The average number of H-bonds was 11.46 ± 2.59 for MApta pro , with the lowest number being four H-bonds, while the average number of Hbonds was 9.67 ± 2.13 for MApta pro -IR1, with the lowest number being three H-bonds, and was 7.96 ± 1.98 with the lowest number being three H-bonds for MApta pro -IR2 (Figure 9 , Table 3 ). The Rg trajectory plot of the MApta pro -IR1/M pro complex was stable after 20 ns, and the oscillation values were negligible ( Figure 8B ). After that, the complex was at equilibrium and confirmed the steady interaction between the aptamer and the protein. This value remained virtually unchanged during the simulation time with an Rg average of 25.94 ± 0.35 Å for the MApta pro -RI1/M pro complex ( Figure 8B) .

Finally, the MApta pro -IR2/M pro complex had an Rg average of 23.04 ± 0.13 Å and was stable after 20 ns with a slight oscillation around 35 ns ( Figure 8C ).

The number of intramolecular H-bonds formed is a measure of the aptamer-protein interaction stability. The total number of H-bonds from MApta pro , MApta pro -IR1, and MApta pro -IR2 in complex with the main protease M pro is shown in Figure 9 . During the simulation time, the number of H-bonds in the MApta pro /M pro complex decreased, while the number of stable H-bonds in the MApta pro -IR1/M pro and MApta pro -IR2/M pro complexes remained nearly unchanged. The average number of H-bonds was 11.46 ± 2.59 for MApta pro , with the lowest number being four H-bonds, while the average number of Hbonds was 9.67 ± 2.13 for MApta pro -IR1, with the lowest number being three H-bonds, and was 7.96 ± 1.98 with the lowest number being three H-bonds for MApta pro -IR2 (Figure 9 , Table 3 ). 

Next, we assessed the relative binding free energies (ΔGbinding) between the aptamers and M pro enzyme by using the Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA) method, often applied for the protein-ligand binding free energy calculation ( Figure 10 ). We also assessed the entropy contribution with the Nmode AMBER module ( Table 4 ).

The median value of ΔGbinding was −80.30 ± 12.73 kcal/mol for MApta pro , -85.03 ± 14.49 

Next, we assessed the relative binding free energies (∆G binding ) between the aptamers and M pro enzyme by using the Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA) method, often applied for the protein-ligand binding free energy calculation ( Figure 10 ). We also assessed the entropy contribution with the Nmode AMBER module (Table 4) . We also calculated the MM/PBSA entropic contributions, TΔS, at 300 K, and combined these results with the MM/PBSA binding energies. Due to the expense of computing the entropic contributions with the Nmode AMBER module, we calculated the abovementioned energies on five snapshots extracted from the representative structure calculated by clustering the trajectory. The representative structure corresponds to a representative snapshot from the most populated cluster. From this, we established the relative order of favorable binding energies: MApta pro -IR1 > MApta pro -IR2 > MApta pro (Table 4) .

Collectively, these data suggest that the most energetically favorable complex was the MApta pro -IR1 aptamer/M pro protein (Video S1). 

In the present work, we have generated de novo ssRNA aptamers against the SARS-CoV-2 M pro protein and demonstrated the formation of a stable aptamer-protein complex in a computational approach. We selected the SARS-CoV-2 M pro as the target of our study based on its key role in the replication of the SARS-CoV-2 virus within infected cells [45] , as well as by the databank information showing the highly-conserved SARS-CoV-2 M pro sequence among other coronaviridae, such as SARS-CoV and MERS-CoV, and the absence of viral mutations, to our knowledge, mostly documented in the spike gene [46] .

Due to these characteristics, SARS-CoV-2 M pro is currently an attractive antiviral candidate, and many molecular drugs with potential antiviral activity are under therapeutic evaluation. These include phytochemicals compounds (e.g., Bonducellpin D. [47] ; glycyrrhizin, tryptanthrine, indirubin, β-sitosterol, hesperetin, β-caryophyllene [48] ), synthesized lead compounds 11a and 11b [24] and Ac-Abu-DTyr-Leu-Gln-VS [25] , and molecular drugs (e.g., boceprevir, calpain inhibitor II, calpain inhibitor XII, GC-376 [49] ; ceftaroline fosamil and telaprevir [50] ; GRL-1720 and 5 h [51] ). Most of these inhibitors have been (Figure 10 ). The trajectories of the MApta pro -M pro interaction indicated an increase in the ∆G binding during the simulation time, and higher stable ∆G binding energy for the MApta pro -IR1/M pro complex compared to MApta pro -RI2/M pro and MApta pro /M pro .

Interestingly, while the ∆G binding of the MApta pro /M pro complex slightly increases in the last 20 ns of the trajectory and MApta pro -IR2/M pro almost remain constant, in the MApta pro -RI1/M pro complex, the ∆G binding decreases from −57.74 kcal/mol to −92.25 kcal/mol ( Figure 10B ), indicating that the interaction between the MApta pro -IR1 aptamer and the M pro enzyme is the strongest and the most stable.

We also calculated the MM/PBSA entropic contributions, T∆S, at 300 K, and combined these results with the MM/PBSA binding energies. Due to the expense of computing the entropic contributions with the Nmode AMBER module, we calculated the abovementioned energies on five snapshots extracted from the representative structure calculated by clustering the trajectory. The representative structure corresponds to a representative snapshot from the most populated cluster. From this, we established the relative order of favorable binding energies: MApta pro -IR1 > MApta pro -IR2 > MApta pro (Table 4) .

Collectively, these data suggest that the most energetically favorable complex was the MApta pro -IR1 aptamer/M pro protein (Video S1).

In the present work, we have generated de novo ssRNA aptamers against the SARS-CoV-2 M pro protein and demonstrated the formation of a stable aptamer-protein complex in a computational approach. We selected the SARS-CoV-2 M pro as the target of our study based on its key role in the replication of the SARS-CoV-2 virus within infected cells [45] , as well as by the databank information showing the highly-conserved SARS-CoV-2 M pro sequence among other coronaviridae, such as SARS-CoV and MERS-CoV, and the absence of viral mutations, to our knowledge, mostly documented in the spike gene [46] .

Due to these characteristics, SARS-CoV-2 M pro is currently an attractive antiviral candidate, and many molecular drugs with potential antiviral activity are under therapeutic evaluation. These include phytochemicals compounds (e.g., Bonducellpin D. [47] ; glycyrrhizin, tryptanthrine, indirubin, β-sitosterol, hesperetin, β-caryophyllene [48] ), synthesized lead compounds 11a and 11b [24] and Ac-Abu-DTyr-Leu-Gln-VS [25] , and molecular drugs (e.g., boceprevir, calpain inhibitor II, calpain inhibitor XII, GC-376 [49] ; ceftaroline fosamil and telaprevir [50] ; GRL-1720 and 5 h [51] ). Most of these inhibitors have been identified by using bioinformatics virtual screening approaches, since many learning platforms have been developed, published, and hourly updated [52, 53] to provide a suitable tool for improving the development of an effective therapeutic approach for the SARS-CoV-2 pandemic. Currently, there is no cure for the SARS-CoV-2 disease.

We chose ssRNA aptamers as antiviral drugs based on their chemical composition and 3D conformation that holds them as natural compounds for clinical purposes [39, [54] [55] [56] [57] [58] [59] [60] [61] . In particular, aptamers, similarly to monoclonal antibodies, interfere specifically with the target and block its function; furthermore, they can be easily transferred to cells using a conventional drug delivery system [62] and can be produced at low costs through a synthetic process. The highest critical step, consisting of the identification of the aptamer with the highest affinity for the target, is generally solved with the SELEX procedure or through the computational approaches [35] .

In our study, we used the computational strategy for predicting the aptamer against the SARS-CoV-2 M pro specific sequence, and for identifying the aptamer(s) with the highest affinity by dynamic molecular simulation. Up to now, there are no available aptamers active against SARS-CoV-2 M pro in the databanks or published reports; therefore, as the first step of our work, we have designed de novo an aptamer specific for SARS-CoV-2 M pro . To the best of our knowledge, there are only two Korean patents that describe the generation of RNA aptamers for the inhibition of the SARS helicase enzyme (#KR2009128837) and those of nucleocapsid of SARS-CoV (#KR2012139512), whereas DNA aptamers targeting the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein have been discovered by using the competition-based selection strategy and a machine learning screening algorithm [63] .

The first ssRNA aptamer (MApta pro ) was designed considering as reference the crystallography of SARS-CoV-2 M pro [18] . From MApta pro , by the RNAinverse process, 207 ssRNA aptamers were generated, which, after molecular docking, allowed the selection of the aptamers MApta pro -IR1 and MApta pro -IR2 as the structures with the best docking energy. Notably, MApta pro , MApta pro -IR1, and MApta pro -IR2 have a similar 3D conformation and almost fall in the same structural region of SARS-CoV-2 M pro , that is, the dimerization region of the protein necessary for the enzymatic activity [45] . Furthermore, dynamic molecular simulation and the free binding energy calculation have shown that the three aptamers formed a stable complex with the SARS-CoV-2 M pro and highlighted that the complex MApta pro -IR1/SARS-CoV-2 M pro was the most favorable. We speculated that this is the consequence of the capability of MApta pro -IR1 to form H-bonds with Arg4 and Ser139, whereas MApta pro and MApta pro -IR2 form only H-bonds with Arg4. Both amino acids are part of the amino acid Arg4, Ser10, Gly11, Glu14, Asn28, Ser139, Phe140, Ser147, Glu290, Arg298 residues that are necessary for the dimerization process of SARS-CoV-2 M pro monomers [45] . In particular, it is reported that Ser139 is one of the amino acids close to the binding site necessary for enzyme activity since its substitution impaired the dimerization process, thus inhibiting enzyme activity [45, 64] , whereas, Arg4 is necessary for the dimerization as its substitution causes a 5-fold decrease of this process [45, 65] .

The overall characteristics highlighted MApta pro -IR1 as the best potential candidate for the inhibition of SARS-CoV-2 M pro and useful as a therapeutic drug for the COVID-19 disease.

To the best of our knowledge, our results are the pioneer for predicting ssRNA aptamers as molecular drugs against SARS-CoV-2 M pro and, through this perspective, in combatting the SARS-CoV-2 pandemic. MAWS is an entropic fragment-based algorithm that can create aptamers against target molecules without the need for an initial aptamer sequence or pool [36] . The MAWS algorithm was slightly modified in (1) forcefield name = "leaprc.protein.ff14SB" and (2) "residue.name" for RNA instead of DNA, to generate an RNA aptamer. The algorithm requires a target molecule to be loaded, and then a bounding box is created. The crystal structure of M pro (PDB ID: 6LU7) is taken from Protein Data Bank [22, 66] ; it is cleaned and unwanted molecules are removed. Next, during the initial sampling, nucleotides are sampled from a uniform distribution, "docked" and the nucleotide with the lowest entropy is chosen as the starting point. Then, possible conformations of the next nucleotide in the sequence are sampled and the sequence with the lowest energy is chosen. This process is continued until the aptamer is designed (step 1, Figure 11 ). The MAWS software creates an aptamer of a maximum length of 30mer, so in step 2 the aptamer was extended to 40mer by adding 5 -GGGGG and 3 -CCCCC. 

MAWS is an entropic fragment-based algorithm that can create aptamers against target molecules without the need for an initial aptamer sequence or pool [36] . The MAWS algorithm was slightly modified in (1) forcefield name = "leaprc.protein.ff14SB" and (2) "residue.name" for RNA instead of DNA, to generate an RNA aptamer. The algorithm requires a target molecule to be loaded, and then a bounding box is created. The crystal structure of M pro (PDB ID: 6LU7) is taken from Protein Data Bank [22, 66] ; it is cleaned and unwanted molecules are removed. Next, during the initial sampling, nucleotides are sampled from a uniform distribution, "docked" and the nucleotide with the lowest entropy is chosen as the starting point. Then, possible conformations of the next nucleotide in the sequence are sampled and the sequence with the lowest energy is chosen. This process is continued until the aptamer is designed (step 1, Figure 11 ). The MAWS software creates an aptamer of a maximum length of 30mer, so in step 2 the aptamer was extended to 40mer by adding 5′-GGGGG and 3′-CCCCC. Starting from this 40mer aptamer sequence ( Figure 11 , step 2), the Mutate Predict Dock Repeat (MPDR) algorithm [37, 67] was used to generate 200 mutated 3D structures of RNA aptamers. The original MPDR algorithm was only modified using ZDOCK, instead of an HADDOCK server, for its ability to run locally and rapidly on a personal computer.

All of the computations were performed on an Ubuntu18 desktop PC, with a [AMD Ryzen 9 5950x CPU (16 Cores) + 64GB RAM + 1 NVIDIA GeForce RTX 3090] configuration.

Starting from the best de novo 40mer 3D aptamer, we also derive the secondary structure through RNAPDBEE [68, 69] and submit then to the RNAinverse process by using the ViennaRNA web server [70, 71] for finding a sequence that adopts a given secondary structure. The RNAinverse algorithm starts with a selected nucleotide sequence and keeps changing nucleotides until the RNA sequence adopts the desired fold. A total of 207 sequences were generated and the 3D structure was further modeled using ViennaRNA for secondary structure detection [44] , SimRNA 3D [72] for structure prediction from the sequence, and QRNA 3D [73] for refinement and energy minimization ( Figure 12 ). Starting from this 40mer aptamer sequence ( Figure 11 , step 2), the Mutate Predict Dock Repeat (MPDR) algorithm [37, 67] was used to generate 200 mutated 3D structures of RNA aptamers. The original MPDR algorithm was only modified using ZDOCK, instead of an HADDOCK server, for its ability to run locally and rapidly on a personal computer.

All of the computations were performed on an Ubuntu18 desktop PC, with a [AMD Ryzen 9 5950x CPU (16 Cores) + 64GB RAM + 1 NVIDIA GeForce RTX 3090] configuration.

Starting from the best de novo 40mer 3D aptamer, we also derive the secondary structure through RNAPDBEE [68, 69] and submit then to the RNAinverse process by using the ViennaRNA web server [70, 71] for finding a sequence that adopts a given secondary structure. The RNAinverse algorithm starts with a selected nucleotide sequence and keeps changing nucleotides until the RNA sequence adopts the desired fold. A total of 207 sequences were generated and the 3D structure was further modeled using ViennaRNA for secondary structure detection [44] , SimRNA 3D [72] for structure prediction from the sequence, and QRNA 3D [73] for refinement and energy minimization ( Figure 12 ). 

All generated structures were subjected to virtual screening. For docking analysis, in this study, three different software docking algorithms-ZDOCK [74] , HDOCK [75] , and QVINA-W [76, 77] -were used for predicting the structures of protein-RNA complexes.

Before docking, the crystal structure of M pro (PDB ID: 6LU7) was taken from the Protein Data Bank [22, 66] , was cleaned and unwanted molecules were removed.

The latest version, ZDOCK 3.0.2 [78] , was used in this study with the AMBER94 force field for improving accuracy in RNA-protein rigid-body docking [79] . Its docking procedure was performed with the default settings: variable grid size for fitting the size of a protein and RNA, a 1.2Å grid step, with a 15° angle step for rotation of the ligand, and -N 5000 (number of output predictions).

The HDOCK server, for integrated protein-RNA and protein-protein docking [79] automatically predicts their interaction through a hybrid algorithm of template-based and template-free docking. The cleaned protein and RNA aptamer were loaded on the web server and docked with standard parameters.

To perform the docking with QVINA-W, the protein and RNA were prepared with AutoDockTools. For protein preparation, the standard script 'prepare_receptor4.py' was used, while for RNA preparation all active torsions were inactivated through 'prepare_lig-and4.py -Z'.

All of the docking simulations were performed on an Ubuntu18 desktop PC, with a [AMD Ryzen 9 5950x CPU (16 Cores) + 64GB RAM + 1 NVIDIA GeForce RTX 3090] configuration.

The MD simulation was carried out based on the complex obtained from docking with ZDOCK software. The complex using in the simulation was prepared with CHARMM-GUI [80] .

Each simulation system was prepared in a periodic rectangular simulation cubic box, hydrated with a TIP3P [81] water model, and neutralized with a 0.15M NaCl solution. The box dimensions were chosen to provide at least 30Å buffers of solvent molecules around the solute.

All simulations were performed using the molecular dynamics software AMBER16 [82] , the amber ff14SB force field for protein [83] , and χOL3 force fields for RNA [84] . This combination has shown satisfactory behavior with other protein-RNA complexes [85] . 

All generated structures were subjected to virtual screening. For docking analysis, in this study, three different software docking algorithms-ZDOCK [74] , HDOCK [75] , and QVINA-W [76, 77] -were used for predicting the structures of protein-RNA complexes.

Before docking, the crystal structure of M pro (PDB ID: 6LU7) was taken from the Protein Data Bank [22, 66] , was cleaned and unwanted molecules were removed.

The latest version, ZDOCK 3.0.2 [78] , was used in this study with the AMBER94 force field for improving accuracy in RNA-protein rigid-body docking [79] . Its docking procedure was performed with the default settings: variable grid size for fitting the size of a protein and RNA, a 1.2 Å grid step, with a 15 • angle step for rotation of the ligand, and -N 5000 (number of output predictions).

The HDOCK server, for integrated protein-RNA and protein-protein docking [79] automatically predicts their interaction through a hybrid algorithm of template-based and template-free docking. The cleaned protein and RNA aptamer were loaded on the web server and docked with standard parameters.

To perform the docking with QVINA-W, the protein and RNA were prepared with AutoDockTools. For protein preparation, the standard script 'prepare_receptor4.py' was used, while for RNA preparation all active torsions were inactivated through 'prepare_ligand4.py -Z'.

All of the docking simulations were performed on an Ubuntu18 desktop PC, with a [AMD Ryzen 9 5950x CPU (16 Cores) + 64GB RAM + 1 NVIDIA GeForce RTX 3090] configuration.

The MD simulation was carried out based on the complex obtained from docking with ZDOCK software. The complex using in the simulation was prepared with CHARMM-GUI [80] .

Each simulation system was prepared in a periodic rectangular simulation cubic box, hydrated with a TIP3P [81] water model, and neutralized with a 0.15 M NaCl solution. The box dimensions were chosen to provide at least 30 Å buffers of solvent molecules around the solute.

All simulations were performed using the molecular dynamics software AMBER16 [82] , the amber ff14SB force field for protein [83] , and χ OL3 force fields for RNA [84] . This combination has shown satisfactory behavior with other protein-RNA complexes [85] .

All systems were subjected to energy minimization and equilibration using a standard equilibration protocol [85] . Initially, each system was minimized by applying a maximum force of 5 kcal/mol/Å 2 and 5000 steps steepest descent to remove clashes between atoms, followed by another 3 cycles of gradually relaxing minimization to 0.05 kcal/mol/Å 2 .

Before the simulation, each system was equilibrated through 3 cycles of 50 ps, gradually relaxing from 5 kcal/mol/Å 2 to 0.1 kcal/mol/Å 2 performed for each system at constant pressure (1 atm) and temperature (300 K). The temperature and pressure were kept constant during the simulation. Temperature coupling was done using the Berendsen thermostat with a temperature coupling constant of 0.5 ps, while the Berendsen barostat method was used for pressure coupling, with a reference pressure of 1 atm. The particle mesh Ewald approach [86, 87] was used to calculate the long-range electrostatic, and a cut-off distance of 12Å was used for the van der Waals interactions (the non-bonded Lennard-Jones terms). The chemical bond lengths involving hydrogen atoms were constrained with the SHAKE algorithm. After equilibration, 100ns completely unrestrained MD simulations were performed.

All MD simulations were performed with a Linux16 image as a Google Compute Engine instance on Google Cloud Platform (8 vCPU, 30 GB RAM, GPU 1 × NVIDIA Tesla V100).

To study the stability of the M pro -specific aptamer structures over the 100ns simulation time, various analytical methods were employed.

The trajectories of the MD simulations were examined with cpptraj implemented in AmberTools20 (e.g., RMSD, Radius of gyration, and H-bond frequency) [88] . Principal Component Analysis on trajectory was performed using the bio3D library in R v3.6.1 (R Core Team, Wien, Austria) [89] [90] [91] .

The free binding energies of the complex between the aptamer and M pro were analyzed during the 100 ns MD simulations with MMPBSA.py implemented in AmberTools20 [82, 92] . The Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA) [93, 94] implicit solvent model is one of the most widely used methods to compute the binding free energy. In this work, the binding free energy, ∆G binding , is estimated from computational analysis of a single system simulation (only complex).

According to the MM/PBSA method, binding free energy (∆G binding ) is calculated by subtracting the free energies of the unbound receptor and ligand from the free energy of the bound complex:

∆Gbinding,solvated = Gcomplex,solvated − (Gprotein,solvated + Gligand,solvated) (1)

In addition, the binding free energy (∆G binding ) consists of two parts: ∆Gbinding = ∆Ggas + ∆Gsolv = (∆GMM-T∆S) + ∆Gsolv (2)

where ∆Gele,int and ∆GVDW,int represent the electrostatic and van der Walls energetic interactions, respectively. The solvation free energy in Equation (2) can be expressed as: ∆Gsolv = ∆Gele,solv + ∆Gnonpolar,solv = ∆GPB + ∆GNP

For each snapshot collected during the simulation, ligand-receptor interaction energies (∆GMM) and the solvation energies (∆Gsolv) were calculated with the MM/PBSA program implemented in AmberTools. The entropy contribution toward the binding free energy, T∆S, was computed by the AMBER NMODE (Nmode) module [95] .

However, considering that it would be extremely time-consuming and computationally expensive to calculate the entropy contribution, we only extract 5 snapshots from the trajectory to calculate T∆S. The snapshots are extracted from the representative structure. A representative structure was calculated by clustering the trajectory using the amber module cpptraj. The representative structure corresponds to a representative snapshot from the most populated cluster.

All the pictorial structure presentations were prepared using VMD-Visual Molecular Dynamics v1.9.4 (Theoretical and Computational Biophysics Group at the Beckman Institute for Advanced Science and Technology, University of Illinois, Urbana-Champaign) and PyMOL Molecular Graphics System v1.8.6.0 (Schrödinger, LLC, New York City, NY, USA). Molecular video of the 100ns trajectory of the selected best aptamer in complex with M pro (Video S1) was prepared with UCSF Chimera v1.14 (developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, CA, USA). Graphical analysis was performed with GraphPad Prism 6 (GraphPad Software, La Jolla, CA, USA).

Herein, computational simulations probed three candidate ssRNA aptamer inhibitors of M pro . Two subsequential different approaches were used to optimize the initial sequence and its structure: (i) an elitist genetic algorithm that takes several potential solutions to a problem, creates offspring from them by adding variations (much like mutations), and then chooses the best solutions from the pool; and (ii) one followed by the RNA inverse process, which generates structure from a given sequence that folds into the target RNA structure.

We applied molecular docking, molecular dynamics, and binding free energy analysis to investigate the binding mechanism of several aptamers to SARA-CoV-2 M pro , and this is the first report to study the binding of an RNA molecule to the COVID-19 main protease. The screening of de novo designed aptamers retrieved 407 structures as candidate inhibitors of M pro .

The docking of candidate inhibitors filtered 12 structures with a docking ZDOCK score >1536 and established polar and non-polar interactions with the M pro residues. Finally, molecular dynamics simulation and binding free energy analyses identified one candidate inhibitor of M pro with the highest energy. During the 100ns simulation, the final candidate inhibitor established stable hydrogen-bond interactions with the M pro Arg4 and Ser139 residues important for the dimerization and function of M pro and obtained the lowest binding energies of −29.93 kcal/.

This study contributes to the understanding of how proteins binding with aptamer structures in an aqueous solution behave and may facilitate further infective drug design targeting the SARS-CoV-2 M pro . The workflow created allows for the development and testing of further attractive ligand-aptamer complexes. 

COVID-19) Dashboard|WHO Coronavirus Disease (COVID-19) Dashboard

Treatment for COVID-19: An Overview

Identification of Potential Antivirals against SARS-CoV-2 Using Virtual Screening Method

An Update to Monoclonal Antibody as Therapeutic Option against COVID-19

Maintaining Safety with SARS-CoV-2 Vaccines

Therapeutics and Vaccines: Strengthening Our Fight Against the Global Pandemic COVID-19

COVID-19: A Review of Therapeutic Strategies and Vaccine Candidates

Viral Targets for Vaccines against COVID-19

SARS-CoV-2 Spike D614G Change Enhances Replication and Transmission

SARS-CoV-2 Variants of Concern|CDC. Available online

Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding

A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2

Targeting the Entry Step of SARS-CoV-2: A Promising Therapeutic Approach

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis

The Coding Capacity of SARS-CoV-2

Genotype and Phenotype of COVID-19: Their Roles in Pathogenesis

Crystal Structure of SARS-CoV-2 Main Protease Provides a Basis for Design of Improved a-Ketoamide Inhibitors

The Crystal Structures of Severe Acute Respiratory Syndrome Virus Main Protease and Its Complex with an Inhibitor

Activation and Maturation of SARS-CoV Main Protease

Structural Stability of SARS-CoV-2 3CLpro and Identification of Quercetin as an Inhibitor by Experimental Screening

Structure of Mpro from SARS-CoV-2 and Discovery of Its Inhibitors

Structural and Evolutionary Analysis Indicate That the Sars-COV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design

Structure-Based Design of Antiviral Drug Candidates Targeting the SARS-CoV-2 Main Protease

SARS-CoV-2 Mpro Inhibitors and Activity-Based Probes for Patient-Sample Imaging

An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy

Characterization and Inhibition of the Main Protease of Severe Acute Respiratory Syndrome Coronavirus. ChemBioEng Rev

The Interaction between Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase and a Dimeric Inhibitor by Capillary Electrophoresis

The N-Terminal Octapeptide Acts as a Dimerization Inhibitor of SARS Coronavirus 3C-like Proteinase

Mechanism of Protein-RNA Recognition: Analysis Based on the Statistical Mechanics of Hydration

Aptamers as Targeted Therapeutics: Current Potential and Challenges

Nucleic Acid Aptamer Application in Diagnosis and Therapy of Colorectal Cancer Based on Cell-SELEX Technology

Aptamer-Drug Conjugates

Current Perspectives on Aptamers as Diagnostic Tools and Therapeutic Agents

Methods and Applications of in Silico Aptamer Design and Modeling

Team:Athens/Software-2019.Igem.Org. Available online

Silico Designed RNA Aptamer against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging

Silico Selection of an Aptamer to Estrogen Receptor Alpha Using Computational Docking Employing Estrogen Response Elements as Aptamer-Alike Molecules

Molecular Dynamics Simulation Analysis of Anti-MUC1 Aptamer and Mucin 1 Peptide Binding

Molecular Dynamics Simulations of Aptamer-Binding Reveal Generalized Allostery in Thrombin

Molecular Dynamics Simulation of a RNA Aptasensor

Fast Folding and Comparison of RNA Secondary Structures

ViennaRNA Package 2.0

Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain That Escape Antibody Recognition

Unravelling Lead Antiviral Phytochemicals for the Inhibition of SARS-CoV-2 Mpro Enzyme through in Silico Approach

Recognition of Natural Products as Potential Inhibitors of COVID-19 Main Protease (Mpro): In-Silico Evidences

GC-376, and Calpain Inhibitors II, XII Inhibit SARS-CoV-2 Viral Replication by Targeting the Viral Main Protease

A Computational Drug Repurposing Approach in Identifying the Cephalosporin Antibiotic and Anti-Hepatitis C Drug Derivatives for COVID-19 Treatment

A Small Molecule Compound with an Indole Moiety Inhibits the Main Protease of SARS-CoV-2 and Blocks Virus Replication

Virtual Screening of Approved Drugs as Potential SARS-CoV-2 Main Protease Inhibitors

Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds

Computational Selection of RNA Aptamer against Angiopoietin-2 and Experimental Evaluation

Selection of Aptamers Targeting the Sialic Acid Receptor of Hemagglutinin by Epitope-Specific SELEX

Development of SsDNA Aptamers as Potent Inhibitors of Mycobacterium Tuberculosis Acetohydroxyacid Synthase

Screening Platform toward New Anti-HIV Aptamers Set on Molecular Docking and Fluorescence Quenching Techniques

Entropic Fragment-Based Approach to Aptamer Design

Silico Selection of RNA Aptamers

Rational Truncation of an RNA Aptamer to Prostate-Specific Membrane Antigen Using Computational Structural Modeling. Nucleic Acid Ther

Silico Aptamer Docking Studies: From a Retrospective Validation to a Prospective Case Study'TIM3 Aptamers Binding

Key Aspects of Nucleic Acid Library Design for in Vitro Selection

Discovery of Aptamers Targeting the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein

Identification of Novel Inhibitors of the SARS Coronavirus Main Protease 3CLpro

Quaternary Structure of the Severe Acute Respiratory Syndrome (SARS) Coronavirus Main Protease

RNApdbee 2.0: Multifunctional Tool for RNA Structure Annotation

The ViennaRNA Web Services

SimRNA: A Coarse-Grained Method for RNA Folding Simulations and 3D Structure Prediction

QRNAS: Software Tool for Refinement of Nucleic Acid Structures

Improved Accuracy in RNA-Protein Rigid Body Docking by Incorporating Force Field for Molecular Dynamics Simulation into the Scoring Function

HDOCK: A Web Server for Protein-Protein and Protein-DNA/RNA Docking Based on a Hybrid Strategy

Accurate, and Reliable Molecular Docking with QuickVina 2

Protein-Ligand Blind Docking Using QuickVina-W with Inter-Process Spatio-Temporal Integration

Interactive Docking Prediction of Protein-Protein Complexes and Symmetric Multimers

Comparison of Simple Potential Functions for Simulating Liquid Water

The Amber Molecular Dynamics Package

Improving the Accuracy of Protein Side Chain and Backbone Parameters from Ff99SB

Refinement of the Cornell et Al. Nucleic Acids Force Field Based on Reference Quantum Chemical Calculations of Glycosidic Torsion Profiles

Can We Execute Stable Microsecond-Scale Atomistic Simulations of Protein-RNA Complexes?

Particle Mesh Ewald: An N·log(N) Method for Ewald Sums in Large Systems

A Smooth Particle Mesh Ewald Method

The Bio3D Packages for Structural Bioinformatics

R: A Language and Environment for Statistical Computing

The R Project for Statistical Computing

Py: An Efficient Program for End-State Free Energy Calculations

Assessing the Performance of MM/PBSA and MM/GBSA Methods. 3. The Impact of Force Fields and Ligand Charge Models

Assessing the Performance of MM/PBSA and MM/GBSA Methods. 4. Accuracies of MM/PBSA and MM/GBSA Methodologies Evaluated by Various Simulation Protocols Using PDBbind Data Set

On Finding Stationary States on Large-Molecule Potential Energy Surfaces

We thank Antonio Macchiarulo from the University of Perugia for the critical discussion of the results.

The authors declare no conflict of interest.